10x Genomics Reports Third Quarter 2025 Financial Results
Provided By PR Newswire
Last update: Nov 6, 2025
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025.
Read more at prnewswire.com20.13
+1.79 (+9.76%)
Find more stocks in the Stock Screener
TXG Latest News and Analysis
18 days ago - By: Chartmill
